Inhibition of ULK1/2 and KRASG12C controls tumor growth in preclinical models of lung cancer

Phaedra C. Ghazi(University of Utah), Martin McMahon(UCSF Helen Diller Family Comprehensive Cancer Center)
eLife
May 13, 2024
Cited by 11


Related Papers